Purple Biotech Ltd (PPBT)
0.8075
-0.05
(-5.51%)
USD |
NASDAQ |
May 31, 16:00
0.8052
0.00 (0.00%)
Pre-Market: 20:00
Purple Biotech Shareholders Equity (Quarterly): 31.02M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 31.02M |
December 31, 2023 | 34.21M |
September 30, 2023 | 38.60M |
June 30, 2023 | 42.60M |
March 31, 2023 | 46.88M |
December 31, 2022 | 46.91M |
September 30, 2022 | 51.89M |
June 30, 2022 | 55.41M |
March 31, 2022 | 58.06M |
December 31, 2021 | 64.83M |
September 30, 2021 | 69.06M |
June 30, 2021 | 71.80M |
March 31, 2021 | 74.75M |
December 31, 2020 | 79.39M |
June 30, 2020 | 55.74M |
Date | Value |
---|---|
December 31, 2019 | 10.42M |
June 30, 2019 | 10.99M |
June 30, 2019 | 10.99M |
December 31, 2018 | 10.52M |
June 30, 2018 | 10.14M |
December 31, 2017 | 7.408M |
June 30, 2017 | 10.64M |
December 31, 2016 | 13.38M |
June 30, 2016 | 7.072M |
June 30, 2016 | 7.072M |
December 31, 2015 | 9.429M |
September 30, 2015 | 0.131M |
June 30, 2015 | 1.132M |
June 30, 2015 | 1.132M |
December 31, 2014 | 0.773M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.42M
Minimum
Dec 2019
79.39M
Maximum
Dec 2020
47.42M
Average
49.40M
Median
Shareholders Equity (Quarterly) Benchmarks
Compugen Ltd | 59.68M |
Pluri Inc | -0.356M |
BioLine Rx Ltd | 13.06M |
Can Fite Biofarma Ltd | 6.243M |
BiomX Inc | -9.544M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 39.86M |
Total Liabilities (Quarterly) | 8.772M |